By Kcal da Science Play

Intermittent Fasting: Good for whom?

It is estimated that 38% of the adult population will be overweight and 20% will be obese by 2030. Obesity is a disease characterized by an excessive accumulation of fat that origi

  • No Comments
  • 3 de abril de 2023
By Kcal da Science Play

Weight Loss Programs: Is It Worth It?

Commercial weight loss programs have become increasingly popular and there is now some published evidence documenting their effectiveness, and clinically significant weight loss ha

  • No Comments
  • 3 de abril de 2023
By Kcal da Science Play

Ketogenic Diet in Obesity Control

Obesity has been defined as a “silent killer”, since it significantly increases the risk and contributes to the development of cardiovascular diseases, type 2 diabetes,

  • No Comments
  • 3 de abril de 2023
By Kcal da Science Play

Benefits of Weight Loss in Obesity

Obesity is a chronic multifactorial disease that is associated with increased risks of several other diseases, which include type 2 diabetes (T2D), cardiovascular disease, certain

  • No Comments
  • 20 de março de 2023
By Kcal da Science Play

Ultra-processed foods and mortality in Brazil

Due to the lack of time to eat, the consumption of ultra-processed foods has become frequent. This is one of the aggravating factors for the increase in the number of deaths per ye

  • No Comments
  • 13 de março de 2023
By Kcal da Science Play

Eating more often a day loses more weight?

Does eating more often a day lose weight more? Well, in nutrition the control of body weight is based on energy balance. Specifically, when caloric intake exceeds caloric expenditu

  • No Comments
  • 8 de março de 2023
By Kcal da Science Play

Weight Loss and Intermittent Fasting

Over the years, the increased prevalence of obesity and related metabolic diseases has also reflected an increase in dietary interventions that restrict energy intake in order to p

  • No Comments
  • 2 de março de 2023
By Kcal da Science Play

Saxenda in Slimming: What Do You Need to Know?

It is no longer new that pharmacotherapy can help people with obesity achieve and maintain their weight loss goal, thereby reducing the risk of obesity-related complications. And a

  • No Comments
  • 25 de fevereiro de 2023
By Kcal da Science Play

Diabetes, Obesity and Ozempic: What Do You Need to Know?

Obesity is often a comorbidity of type 2 diabetes mellitus (DM2), since up to 85.2% of people with 2MD are overweight or obese, and it is predicted that by 2025, more than 300 mill

  • No Comments
  • 24 de fevereiro de 2023
By Kcal da Science Play

Berberine in slimming

Obesity is a complex and common metabolic disease, which disrupts the intestinal microbiota, alters energy metabolism, immune response, induces insulin resistance and endogenous me

  • No Comments
  • 21 de fevereiro de 2023